Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 10, Pages e2000915118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-03-02
DOI
10.1073/pnas.2000915118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
- (2020) Carol M. Amato et al. Cancers
- S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
- (2019) Pinyang Cheng et al. LEUKEMIA
- The NLRP3 inflammasome as pharmacological target
- (2019) Carlo Marchetti JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation
- (2019) Nicola Tumino et al. LEUKEMIA
- Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells
- (2019) Hye Eun Lee et al. Scientific Reports
- IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
- (2019) Richard P. Tobin et al. Frontiers in Oncology
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
- (2018) Carl Morrison et al. Journal for ImmunoTherapy of Cancer
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of checkpoint molecules on myeloid-derived suppressor cells
- (2017) Marlene Ballbach et al. IMMUNOLOGY LETTERS
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
- (2017) Yago Pico de Coana et al. Oncotarget
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis
- (2016) Michael Hölzel et al. TRENDS IN IMMUNOLOGY
- On the origin of myeloid-derived suppressor cells
- (2016) Camilla Rydberg Millrud et al. Oncotarget
- Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
- (2016) J. Weber et al. Cancer Immunology Research
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- A role for G-CSF and GM-CSF in nonmyeloid cancers
- (2014) Alexander M. Aliper et al. Cancer Medicine
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
- (2013) Kimberly R. Jordan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NLRP3 Suppresses NK Cell-Mediated Responses to Carcinogen-Induced Tumors and Metastases
- (2012) M. T. Chow et al. CANCER RESEARCH
- Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
- (2012) Joannes FM Jacobs et al. LANCET ONCOLOGY
- Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma
- (2012) Deepti Verma et al. Pigment Cell & Melanoma Research
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Why not treat human cancer with interleukin-1 blockade?
- (2010) Charles A. Dinarello CANCER AND METASTASIS REVIEWS
- IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function
- (2010) Moshe Elkabets et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
- (2009) Miyako Okamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Inflammation and melanoma metastasis
- (2009) Vladislava O. Melnikova et al. Pigment Cell & Melanoma Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started